In type 1 diabetes (T1D), carbohydrates have long been recognized as the primary macronutrient influencing postprandial (after-meal) glucose levels. However, accumulating evidence now highlights that protein also plays a role in postprandial glycemic excursions, although the underlying mechanisms and clinical implications are less widely understood. This growing body of research suggests that protein’s impact on blood glucose should not be overlooked in the dietary management of T1D.

      Protein ingestion leads to elevated plasma amino acid levels, which stimulate glucagon secretion—either directly or via gut hormones like GIP (glucose-dependent insulinotropic polypeptide). In individuals with T1D, the absence of endogenous insulin allows this glucagon response to act unopposed, promoting endogenous glucose production (EGP) in the liver. This results in a moderate but sustained increase in blood glucose levels, often lasting several hours after protein consumption.

      The magnitude of this glycemic response depends heavily on the rate of protein digestion and its amino acid composition. Fast-absorbing proteins such as whey tend to elicit stronger and quicker rises in glucose levels compared to slow-digesting proteins like casein or beef. Therefore, both the type and timing of protein intake are important considerations in managing glycemia.

      While the glycemic index (GI) of carbohydrates is well established, there is currently no similar index for proteins based on their glucose-raising potential. Developing such a tool could greatly enhance insulin dosing strategies and overall glucose control for people with T1D. The concept of a “glycemic index for protein”—based on absorption rates and amino acid profiles—holds promise for more personalized diabetes management.

      Interestingly, this glucagon-stimulating effect of protein, particularly from fast-digesting sources, presents an opportunity beyond meal planning. Emerging evidence supports the use of protein as a strategy to prevent or mitigate hypoglycemia, especially during the night or after exercise—times when the risk of low blood glucose is higher. Unlike carbohydrates, protein offers a more gradual and sustained rise in glucose, which may be better tolerated and less likely to trigger reactive insulin delivery in those using automated insulin delivery systems.

      Despite these promising insights, there remains a lack of well-controlled clinical studies in this area. Further research is essential to validate the therapeutic use of protein and to develop practical guidelines that can be easily implemented in the daily lives of individuals with T1D.

Read More